These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 12240756)
1. Serum selenium levels in patients with head and neck cancer. Yadav SP; Gera A; Singh I; Chanda R J Otolaryngol; 2002 Aug; 31(4):216-9. PubMed ID: 12240756 [TBL] [Abstract][Full Text] [Related]
2. Perioperative changes in osteopontin and TGFβ1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer. Polat B; Kaiser P; Wohlleben G; Gehrke T; Scherzad A; Scheich M; Malzahn U; Fischer T; Vordermark D; Flentje M BMC Cancer; 2017 Jan; 17(1):6. PubMed ID: 28049456 [TBL] [Abstract][Full Text] [Related]
3. Squamous cell carcinoma antigen in serum for monitoring of head and neck and uterine cervical squamous cell carcinomas after radiotherapy. Shirato H; Ichimura W; Wakushima H; Nishioka T; Suzuki K Acta Oncol; 1993; 32(6):663-6. PubMed ID: 8260185 [TBL] [Abstract][Full Text] [Related]
4. Serum levels of interleukins 4 and 10 in head and neck squamous cell carcinoma. Mojtahedi Z; Khademi B; Yehya A; Talebi A; Fattahi MJ; Ghaderi A J Laryngol Otol; 2012 Feb; 126(2):175-9. PubMed ID: 21888745 [TBL] [Abstract][Full Text] [Related]
5. Monitoring of therapy in head and neck patients during the radiotherapy by measurement of Cyfra 21-1. Pradier O; Hille A; Schmiberger H; Hess CF Cancer Radiother; 2002 Feb; 6(1):15-21. PubMed ID: 11899676 [TBL] [Abstract][Full Text] [Related]
6. Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer. Selzer E; Grah A; Heiduschka G; Kornek G; Thurnher D Wien Klin Wochenschr; 2016 May; 128(9-10):320-8. PubMed ID: 26919854 [TBL] [Abstract][Full Text] [Related]
7. A reappraisal of the squamous cell carcinoma antigen as a tumor marker in head and neck cancer. Snyderman CH; D'Amico F; Wagner R; Eibling DE Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1294-7. PubMed ID: 7576477 [TBL] [Abstract][Full Text] [Related]
8. Hsp70--a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck. Gehrmann M; Specht HM; Bayer C; Brandstetter M; Chizzali B; Duma M; Breuninger S; Hube K; Lehnerer S; van Phi V; Sage E; Schmid TE; Sedelmayr M; Schilling D; Sievert W; Stangl S; Multhoff G Radiat Oncol; 2014 Jun; 9():131. PubMed ID: 24912482 [TBL] [Abstract][Full Text] [Related]
9. Trace metals and total antioxidant potential in head and neck cancer patients. Akinmoladun VI; Owotade FJ; Olusanya AA Ann Afr Med; 2013; 12(2):131-4. PubMed ID: 23713022 [TBL] [Abstract][Full Text] [Related]
10. Effect of serum selenium levels on radiotherapy-related toxicity in patients undergoing radiotherapy for head and neck cancer. Eroglu C; Unal D; Cetin A; Orhan O; Sivgin S; Oztürk A Anticancer Res; 2012 Aug; 32(8):3587-90. PubMed ID: 22843950 [TBL] [Abstract][Full Text] [Related]
11. Elevated arginine vasopressin levels in squamous cell cancer of the head and neck. Talmi YP; Wolf GT; Hoffman HT; Krause CJ Laryngoscope; 1996 Mar; 106(3 Pt 1):317-21. PubMed ID: 8614196 [TBL] [Abstract][Full Text] [Related]
12. Prospective study of a panel of tumor markers as prognostic factors in patients with squamous cell carcinoma of head and neck. Kandiloros D; Eleftheriadou A; Chalastras T; Kyriou L; Yiotakis I; Ferekidis E Med Oncol; 2006; 23(4):463-70. PubMed ID: 17303904 [TBL] [Abstract][Full Text] [Related]
13. Serum selenium in head and neck cancer patients--a new marker of tumor activity? Büntzel J; Micke O; Glatzel M; Fröhlich D; Bruns F; Mücke R; Schönekaes KG Anticancer Res; 2005; 25(3A):1711-2. PubMed ID: 16033088 [TBL] [Abstract][Full Text] [Related]
14. Serum vascular endothelial growth factor-A (VEGF-A) as a biomarker in squamous cell carcinoma of head and neck patients undergoing chemoradiotherapy. Srivastava VK; Gara RK; Rastogi N; Mishra DP; Ahmed MK; Gupta S; Goel MM; Bhatt ML Asian Pac J Cancer Prev; 2014; 15(7):3261-5. PubMed ID: 24815480 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of altered blood and tissue glutathione levels in head and neck squamous cell carcinoma cases. Khan SU; Mahjabeen I; Malik FA; Kayani MA Asian Pac J Cancer Prev; 2014; 15(18):7603-9. PubMed ID: 25292035 [TBL] [Abstract][Full Text] [Related]
16. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors. Ozturk B; Coskun U; Sancak B; Yaman E; Buyukberber S; Benekli M Int Immunopharmacol; 2009 May; 9(5):645-8. PubMed ID: 19249390 [TBL] [Abstract][Full Text] [Related]
17. [Status of essential trace elements in untreated carcinomas of the head and neck]. Büntzel J; Glatzel M; Micke O; Fröhlich D Laryngorhinootologie; 2003 Aug; 82(8):573-7. PubMed ID: 12915990 [TBL] [Abstract][Full Text] [Related]
18. Circulating fragments of cytokeratin 19 in patients with head and neck squamous cell carcinoma. Bongers V; Braakhuis BJ; Snow GB Clin Otolaryngol Allied Sci; 1995 Oct; 20(5):479-82. PubMed ID: 8582085 [TBL] [Abstract][Full Text] [Related]
19. Serum level and tissue expression of c-erbB-1 and c-erbB-2 proto-oncogene products in patients with squamous cell carcinoma of the head and neck. Hoffmann TK; Balló H; Braunstein S; Van Lierop A ; Wagenmann M; Bier H Oral Oncol; 2001 Jan; 37(1):50-6. PubMed ID: 11120483 [TBL] [Abstract][Full Text] [Related]
20. Serum biomarkers in head and neck squamous cell cancer. Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]